Skip to main content


The Greater Intermountain Node (GIN; PI: Adam Gordon) was founded and awarded in late Spring 2019 to expand the existing National Institute of Drug Abuse Clinical Trial Network infrastructure by developing and testing innovative interventions for opioid use disorder, preventing overdose, expanding the settings for Network research, and bringing new research expertise to the Network. GIN is housed within the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) within the Division of Epidemiology within the Department of Internal Medicine within the University Of Utah School Of Medicine.

The GIN brings particular expertise in three areas of opioid addiction research to the Utah, regional, and national communities: 1) research within non-addiction specialty health care settings, 2) addiction and opioid research within large health systems of care, and 3) implementation science and approaches to bring addiction evidence-based research to practice. GIN leverages robust institutional commitment and infrastructure, institutional centers focused on addiction-related research, and training programs with strong regional and national connections to clinicians, educators, other institutions and organizations, and community stakeholders. GIN has dedicated space, staff, and faculty to accomplish its missions.

If you're interested in applying your research through the Greater Intermountain Node, check out how to apply and contact us if you have any questions.